济民健康
(603222)
| 流通市值：35.71亿 | | | 总市值：35.71亿 |
| 流通股本：5.25亿 | | | 总股本：5.25亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 231,094,896.75 | 400,121,737 | 282,188,756.89 | 295,283,804.31 |
| 应收票据及应收账款 | 120,841,687.07 | 110,116,117.35 | 110,623,115.56 | 115,815,240.53 |
| 应收账款 | 120,841,687.07 | 110,116,117.35 | 110,623,115.56 | 115,815,240.53 |
| 应收款项融资 | 658,699.24 | 1,612,953.75 | 2,264,351.4 | 2,342,661.52 |
| 预付款项 | 7,417,680.53 | 4,401,146.64 | 8,250,179.25 | 3,971,974.84 |
| 其他应收款合计 | 49,565,698.66 | 49,666,066.94 | 49,622,863.85 | 53,496,646.97 |
| 存货 | 95,788,421.85 | 104,581,318.48 | 104,099,453.07 | 112,687,297.11 |
| 其他流动资产 | 1,408,066 | 2,435,602.93 | 1,653,384.63 | 1,693,803.72 |
| 流动资产合计 | 506,775,150.1 | 672,934,943.09 | 558,702,104.65 | 585,291,429 |
| 非流动资产: | | | | |
| 长期股权投资 | 154,275.37 | 154,841.36 | 161,155,407.34 | 150,156,668 |
| 其他权益工具投资 | 12,657,000 | 12,657,000 | 12,657,000 | 12,657,000 |
| 其他非流动金融资产 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 |
| 固定资产 | 1,153,490,746.74 | 1,173,709,708.69 | 1,191,249,185.89 | 1,208,701,587.7 |
| 在建工程 | 14,574,383.18 | 13,999,115.03 | 1,292,309.73 | 760,566.37 |
| 使用权资产 | 56,775,704.68 | 59,136,154.48 | 60,441,774.03 | 62,806,799.43 |
| 无形资产 | 188,658,430.82 | 190,030,443.63 | 191,833,211.91 | 193,377,246.65 |
| 商誉 | 14,751,033.3 | 14,751,033.3 | 14,751,033.3 | 14,751,033.3 |
| 长期待摊费用 | 41,039,607.22 | 42,782,858.81 | 44,364,097.79 | 45,545,572.48 |
| 递延所得税资产 | 24,237,982.79 | 22,797,728.97 | 24,134,393.81 | 25,301,578.7 |
| 其他非流动资产 | 145,123,679 | 1,341,292.51 | 1,848,261.79 | 4,289,291.39 |
| 非流动资产合计 | 1,657,462,843.1 | 1,537,360,176.78 | 1,709,726,675.59 | 1,724,347,344.02 |
| 资产总计 | 2,164,237,993.2 | 2,210,295,119.87 | 2,268,428,780.24 | 2,309,638,773.02 |
| 流动负债: | | | | |
| 短期借款 | 474,212,040.45 | 471,202,612.7 | 452,229,772.9 | 385,233,026.81 |
| 应付票据及应付账款 | 122,891,912.8 | 114,183,775.14 | 114,819,157.29 | 128,491,605.92 |
| 其中：应付票据 | 17,611,386.05 | 10,484,323.55 | 14,119,600 | 20,593,870 |
| 应付账款 | 105,280,526.75 | 103,699,451.59 | 100,699,557.29 | 107,897,735.92 |
| 预收款项 | 2,140.68 | 5,351.7 | 8,562.72 | 11,773.74 |
| 合同负债 | 39,256,288.83 | 51,044,561.06 | 55,908,124.43 | 52,153,069.28 |
| 应付职工薪酬 | 18,193,393.64 | 16,051,862.17 | 13,772,973.02 | 19,668,527.08 |
| 应交税费 | 8,298,629.58 | 5,790,952.86 | 5,834,476.18 | 8,490,100.03 |
| 其他应付款合计 | 16,268,183.2 | 17,010,876.31 | 35,181,849.75 | 18,818,206.08 |
| 一年内到期的非流动负债 | 52,081,883.31 | 37,780,480.36 | 30,444,965.59 | 17,725,644.78 |
| 其他流动负债 | 2,234,031.46 | 3,727,957.49 | 4,248,819.71 | 3,824,937.26 |
| 流动负债合计 | 733,438,503.95 | 716,798,429.79 | 712,448,701.59 | 634,416,890.98 |
| 非流动负债: | | | | |
| 长期借款 | 209,249,089.48 | 223,748,372.04 | 233,900,161.96 | 247,725,826.92 |
| 租赁负债 | 53,203,874.33 | 53,040,561.3 | 56,540,231.04 | 56,374,769.75 |
| 长期应付款 | 274,939.21 | 387,334.17 | 504,410.2 | 594,332.98 |
| 预计负债 | 30,781,962.48 | 39,306,001.6 | 59,927,800.89 | 60,113,694.7 |
| 递延收益 | 3,681,863.52 | 3,991,535.22 | 4,401,206.92 | 4,860,878.62 |
| 非流动负债合计 | 297,191,729.02 | 320,473,804.33 | 355,273,811.01 | 369,669,502.97 |
| 负债合计 | 1,030,630,232.97 | 1,037,272,234.12 | 1,067,722,512.6 | 1,004,086,393.95 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 525,090,615 | 525,090,615 | 525,090,615 | 525,090,615 |
| 资本公积 | 599,518,440.93 | 599,518,440.93 | 599,518,440.93 | 599,518,440.93 |
| 减:库存股 | 100,090,783.92 | 100,090,783.92 | 100,090,783.92 | 21,986,838.28 |
| 其他综合收益 | 736,141.53 | 1,837,566.32 | 3,047,046.78 | 5,540,938.37 |
| 盈余公积 | 37,369,257.89 | 37,369,257.89 | 37,369,257.89 | 37,369,257.89 |
| 未分配利润 | -8,272,274.48 | 24,470,209.91 | 47,971,860.78 | 73,893,244.8 |
| 归属于母公司股东权益合计 | 1,054,351,396.95 | 1,088,195,306.13 | 1,112,906,437.46 | 1,219,425,658.71 |
| 少数股东权益 | 79,256,363.28 | 84,827,579.62 | 87,799,830.18 | 86,126,720.36 |
| 股东权益合计 | 1,133,607,760.23 | 1,173,022,885.75 | 1,200,706,267.64 | 1,305,552,379.07 |
| 负债和股东权益合计 | 2,164,237,993.2 | 2,210,295,119.87 | 2,268,428,780.24 | 2,309,638,773.02 |
| 公告日期 | 2026-10-30 | 2026-08-26 | 2026-04-30 | 2026-04-30 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |